Results 231 to 240 of about 351,966 (398)

Evaluating Fidelity of reporting in randomized controlled trials on childhood acute lymphocytic leukemia [PDF]

, 2020
Samuel Jellison, Nicholas Hoffsommer, Alexander Hoelscher, Matt Vassar   +3 more
openalex   +1 more source

The Global Burden of Leukemia, 1990–2021: A Systematic Analysis of Prevalence, DALYs, and Risk Factors From the Global Burden of Disease Study

Med Research, EarlyView.
Using data from the Global Burden of Disease Study 2021, we systematically assessed leukemia prevalence and disability‐adjusted life years (DALYs) across 204 countries and territories from 1990 to 2021, stratified by subtype, demographics, and risk factors.
Yuping Wu, Haini Zhang, Shuang Luo, Xiangmei Zhang, Mei Tan, Jinmei Chen, Pei Huang, Yan Chen, Zuochen Du   +8 more
wiley   +1 more source

An improved multiclass classification of acute lymphocytic leukemia using enhanced glowworm swarm optimization. [PDF]

Sci Rep
N S, M K.
europepmc   +1 more source

Prognostic value and outcome for acute lymphocytic leukemia in children with MLL rearrangement: a case-control study. [PDF]

BMC Cancer, 2022
Qiu KY, Zhou DH, Liao XY, Huang K, Li Y, Xu HG, Weng WJ, Xu LH, Fang JP.   +8 more
europepmc   +1 more source

Defective transport as a mechanism of acquired resistance to methotrexate in patients with acute lymphocytic leukemia [PDF]

, 1992
Tania Trippett, Stephan Śchlemmer, Y Elisseyeff, Erdem Göker, M Wächter, Peter G. Steinherz, C Tan, Ellin Berman, JE Wright, A. Rosowsky   +9 more
openalex   +1 more source

Regulation of HIF-1α signaling and chemoresistance in acute lymphocytic leukemia under hypoxic conditions of the bone marrow microenvironment

Cancer Biology & Therapy, 2012
O. Frolova, I. Samudio, J. Benito, R. Jacamo, S. Kornblau, Ana Marković, W. Schober, Hongbo Lu, Y. Qiu, D. Buglio, T. McQueen, S. Pierce, E. Shpall, S. Konoplev, D. Thomas, H. Kantarjian, R. Lock, M. Andreeff, M. Konopleva   +18 more
semanticscholar   +1 more source

CRISPR Enabled Precision Oncology: From Gene Editing to Tumor Microenvironment Remodeling

Med Research, EarlyView.
CRISPR technology has progressed from a prokaryotic immune system to a diverse suite of editing platforms, including Cas nucleases, base and prime editors, and RNA‐targeting enzymes. These advances enable precise genomic and epigenomic interventions, high‐throughput functional screening, and immune engineering.
Kailai Li, Peixin Huang, Yue Qian, Anqi Lin, Jingjun He, Junyi Shen, Li Chen, Kai Miao, Jian Zhang   +8 more
wiley   +1 more source

Impact of DNA Ligase 1 Genotypes on Childhood Acute Lymphocytic Leukemia. [PDF]

In Vivo
Hsu PC, Chen CC, Tsai HW, Chang WS, Pei JS, Wang YC, Lin ML, He JL, Chen SS, Tsai CW, Bau DT.   +10 more
europepmc   +1 more source

1,5-Anhydroglucitol promotes pre-B acute lymphocytic leukemia progression by driving glycolysis and reactive oxygen species formation. [PDF]

BMC Cancer, 2023
Zhu H, Ma H, Dong N, Wu M, Li D, Liu L, Shi Q, Ju X.   +7 more
europepmc   +1 more source

Role of Glutaredoxin-1 and some Oxidative Stress Enzymes in Acute Lymphocytic Leukemia Patients

S. Younes, Luay A. Al-Helaly
openalex   +1 more source